PEABODY, Mass., Jan. 11, 2012 (GLOBE NEWSWIRE) — Analogic Corporation (Nasdaq:ALOG), enabling the world’s medical imaging and aviation security technology, today announced that Jim Green, Analogic’s president and CEO, Michael Levitz, senior vice president and CFO, along with other members of the Company’s senior leadership team, will ring The NASDAQ Stock Market Opening Bell on Thursday, January 12, at 9:30 am ET.
Jim Green commented, “We are proud to be recognized by NASDAQ and to have the honor of ringing The NASDAQ Stock Market Opening Bell. This comes at an opportune time for Analogic. For over 30 years, Analogic has developed leading-edge technologies in computed tomography (CT) and ultrasound, as well as other imaging modalities. In the last few years, we have made a number of changes to the business to take greater advantage of our technical excellence and introduce market-based solutions to drive growth and improved profitability. This has begun to pay off, as evidenced by our 14% revenue growth last fiscal year. We recently launched a comprehensive global re-branding initiative to better reflect our global mission and market-based focus. I can’t think of a better way to ring in the New Year, highlighting our Company’s position in the industry and showcasing our new corporate identity.
Our team and our Company are stronger than ever.”
Analogic is a unified global organization aligned along its three business units of Medical Imaging, Ultrasound, and Security Technology and is focused on its mission to create innovative technologies to advance the practice of medicine and save lives. Looking to the future, the Company will continue its drive to commercialize new breakthroughs in precision imaging; extend its leading ultrasound technology into new adjacent clinical segments; drive new business opportunities in CT; expand imaging content with OEMs; and capitalize on long-term growth in aviation security resulting from the expected recapitalization of the U.S. market and the adoption of higher level threat detection standards, especially in Europe.
Any statements about future expectations, plans, and prospects for the Company, including statements containing the words “believes,” “anticipates,” “plans,” “expects,” and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks relating to product development and commercialization, limited demand for the Company’s products, risks associated with competition, uncertainties associated with regulatory agency approvals, competitive pricing pressures, downturns in the economy, the risk of potential intellectual property litigation, and other factors discussed in our most recent quarterly report filed with the Securities and Exchange Commission. In addition, the
forward-looking statements included in this presentation represent the Company’s views as of the date of this document. While the Company anticipates that subsequent events and developments will cause the Company’s views to change, the Company specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing the Company’s views as of any later date.
Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. We are recognized around the world for advanced imaging systems and technology that enable computed tomography (CT), ultrasound, digital mammography, and magnetic resonance imaging (MRI), as well as automated threat detection for aviation security. Our CT, MRI, digital mammography, and ultrasound transducer products are sold to original equipment manufacturers (OEMs), providing state-of-the-art capability and enabling them to enter new markets and expand their existing market presence. Our market-leading BK Medical branded ultrasound systems, used in procedure-driven markets such as urology, guided surgery, and anesthesia, are sold to clinical end users through our direct sales force. For over 40 years we’ve enabled customers to thrive, improving
the health and ensuring the safety of people around the world. Analogic is headquartered just north of Boston, Massachusetts. For more information, visit www.analogic.com.
Analogic is a registered trademark of Analogic Corporation.
The globe logo is a trademark of Analogic Corporation.
CONTACT: Mark Namaroff Director of Investor Relations & Corporate Marketing (978) 326-4058 firstname.lastname@example.org